Treat Anxiety, Depression, and Insomnia with the Alpha-Stim® AID

The Alpha-Stim® AID is a Cranial Electrotherapy Stimulation (CES) device that uses low-level electrical current to safely and effectively treat anxiety, depression, and insomnia. Initially cleared by the FDA in 1992 as a prescriptive, noninvasive treatment, CES has an extensive safety record, with few side effects (less than 1%) and considerable scientific evidence of the significant results patients can achieve.

Alpha-Stim treatments are cumulative; however, most patients show at least some improvement after the first treatment
Alpha-Stim technology is safe, with no serious adverse events reported in over 30 years of clinical use
Alpha-Stim devices can be used as a first-line therapy, or as an adjunct to pharmacotherapy (without polypharmacy effects)
The Foundation: A Patented Waveform
  • The only rigorously tested CES waveform designed and refined to improve effectiveness
  • Delivers a very low level of current in pulsed microcurrents of less than one milliampere
  • Effectively targets cell receptors, activating them through frequency matching in a manner similar to chemical ligands
Alpha-Stim Waveform
The Impact: An Electrical Intervention
  • The brain functions electrochemically and can be readily modulated by electrical intervention1,2
  • Alpha-Stim impacts the electrochemical functions of the brain to improve patients’ emotional and physiologic states
    • Designed to effect the activity of subcortical brain structures known to regulate emotions
    • fMRI studies demonstrate the waveform current changes the appropriate brain structures
The Results:
Significant Improvement, Quickly, With Lasting Effect

Electroencephalographic studies show:

  • Increased alpha activity
  • Decreased delta activity
  • Decreased beta activity

As the leader in CES, Alpha-Stim has helped clinicians around the world offer fast, safe, and effective relief for patients suffering from anxiety, depression, and insomnia.

VIEW PRODUCT BROCHURE (multilingual options available)

FFT Relative Power Difference (%)

qEEG changes in 30 subjects treated with 20 minutes of Alpha Stim CES. There is an increase (Red) in alpha activity with a simultaneous decrease (Blue) in beta and delta2.
  1. Heffernan M. Comparative effects of microcurrent stimulation on EEG spectrum and correlation dimension. Integrative Physiological and Behavioral Science. 1996; 31(3):202-209.
  2. Kennerly R. Changes in quantitative EEG and low resolution tomography following cranial electrotherapy stimulation. PhD Dissertation, the University of North Texas. 2006;529 pp., 81 tables, 233 figures, 171 references.